# Japanese phase1 Study of Belimumab (IV vs SC)

> **NCT01516450** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 16 (actual)

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

- **DRUG:** GSK1550188 IV
- **DRUG:** GSK1550188 SC

## Key facts

- **NCT ID:** NCT01516450
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12-26
- **Primary completion:** 2012-04-11
- **Final completion:** 2012-04-11
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2017-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01516450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01516450, "Japanese phase1 Study of Belimumab (IV vs SC)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01516450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*